AVE

AVECHO FPO [AVE]
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Healthcare · ASX Small Cap
$0.0210 -4.6%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when AVE triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track AVE — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Beating the Small Ords index — relative strength of 1.51, so it's outpacing the pack
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Trading above the 200-day average — the long-term trend is on your side
  • Cash positive / operating cashflow positive
  • Very high P/S ratio (65.6x)
  • Revenue in sharp decline (-17%)
  • Small-cap ($20-100M)
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 114% over the past year (excluding last month)
  • Excellent risk-adjusted returns — Sharpe of 1.7 means strong gains without wild swings
  • The bigger volume days are the up days — volume-weighted momentum is positive (9.94%/day)
  • Low-priced stock risk ($0.021)
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 9d (+5pts)

Risk Signals

  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -17% — the top line is shrinking
Ask Scout AI about AVE
"What's driving AVE today?" "How does AVE compare to peers?" "Key risks for AVE?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Application for quotation of securities - AVE
HIGH Positive Phase III Interim Analysis Results Investor Webinar
HIGH Positive interim results from Phase III insomnia program
HIGH Phase III Interim Analysis Outcome Webinar
NEGATIVE Trading Halt

Recent ASX Announcements

2026-06-30 Application for quotation of securities - AVE
2026-06-23 Positive Phase III Interim Analysis Results Investor Webinar
2026-06-23 Positive interim results from Phase III insomnia program PRICE SENSITIVE
2026-06-22 Phase III Interim Analysis Outcome Webinar
2026-06-21 Trading Halt PRICE SENSITIVE

Key Metrics

$81.1M
Market Cap
24.0M
Avg Volume
0.7x
Vol Ratio
$0.00 — $0.03
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-182.9%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 60%
LLeader vs LaggardpassRS: 26
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

111 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
ECS +20.0%VHL -15.4%NTI +12.5%PIQ -11.4%OSL -10.3%
Compare:AVE vs ECSAVE vs VHLAVE vs NTI
Scout Pro — Deeper Analysis for AVE
Try Pro free for 30 days
Share this analysis

Track AVE and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required